Tuberculosis extensamente resistente (XDR-TB) en Argentina: aspectos destacables epidemiológicos, bacteriológicos, terapéuticos y evolutivos

Abbate, Eduardo; Vescovo, Marisa; Natiello, Marcela; Cufré, Mónica; García, Ana; Ambroggi, Marta; Poggi, Susana; Simboli, Norberto; Ritacco, Viviana.
Rev. argent. med. respir ; 7(1): 19-25, sept. 2007. tab
Artículo en Español | LILACS | ID: lil-528636

Documentos relacionados

  1. Global burden of MDR-TB and XDR-TB attributable to high fasting plasma glucose from 1990 to 2019: a retrospective analysis based on the global burden of disease study 2019.
  2. Use of a whole genome sequencing-based approach for <i>Mycobacterium tuberculosis</i> surveillance in Europe in 2017-2019: an ECDC pilot study.
  3. Transmission of multidrug-resistant tuberculosis within family households by DTM-PCR and MIRU-VNTR genotyping.
  4. Time to commencement of effective treatment in patients with drug-resistant tuberculosis diagnosed in the Torres Strait-Papua New Guinea cross-border region.
  5. Emergence and evolution of drug-resistant Mycobacterium tuberculosis in eastern China: A six-year prospective study.
  6. Spatial Analysis of Drug-Susceptible and Multidrug-Resistant Cases of Tuberculosis, Ho Chi Minh City, Vietnam, 2020-2023.
  7. MDR Tuberculosis Treatment.
  8. Determinants of catastrophic costs among households affected by multi-drug resistant tuberculosis in Ho Chi Minh City, Viet Nam: a prospective cohort study.
  9. Improving tuberculosis surveillance by detecting international transmission using publicly available whole genome sequencing data.
  10. [An emergent multidrug resistant fungal pathogen in Argentina].